Celgene
Data Breaches, Cyber Attacks and Security Report

https://celgene.com  ᛫  Biotech & Pharmaceuticals
Last updated September 21, 2019

About Celgene

Company Overview

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients.

Valuation

$58,143,382,000

Employees

8,360

CEO

Mark J. Alles

Location

Summit, NJ, United States.

Data Breaches and Security News

Celgene Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Celgene is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Celgene

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Celgene's security performance with other companies